Clinical Trials Logo

Filter by:
NCT ID: NCT03768492 Active, not recruiting - Carcinoma Breast Clinical Trials

Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy

ReDCoAT
Start date: December 13, 2019
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate whether a caffeine-based cream can reduce the rates of reconstructive complications in patients with tissue expander based reconstruction requiring post-mastectomy radiation therapy when compared to a placebo cream.

NCT ID: NCT03768414 Active, not recruiting - Clinical trials for Stage III Intrahepatic Cholangiocarcinoma AJCC v8

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

Start date: February 7, 2019
Phase: Phase 3
Study type: Interventional

This phase III trial studies how well gemcitabine hydrochloride and cisplatin given with or without nab-paclitaxel work in treating patients with newly diagnosed biliary tract cancers that have spread to other places in the body. Drugs used in chemotherapy, such as gemcitabine hydrochloride, cisplatin, and nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not known if giving gemcitabine hydrochloride and cisplatin with or without nab-paclitaxel may work better at treating biliary tract cancers.

NCT ID: NCT03768349 Active, not recruiting - Prostate Cancer Clinical Trials

PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer

Start date: January 3, 2019
Phase: Early Phase 1
Study type: Interventional

Imaging and staging of prostate cancer is critical for surgical and treatment planning. In this protocol we will image patients with suspected metastatic prostate cancer using 11C-Choline PET and Gallium-68 labeled HBED-CC PSMA (more commonly called 68Ga-PSMA-11) or F-18 labeled PSMA 1007 in order to demonstrate their utility in detecting prostate cancer.

NCT ID: NCT03768336 Active, not recruiting - Cancer Clinical Trials

A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

This research study aims to explore the feasibility and acceptability of an adapted resiliency group program, called the Relaxation Response Resiliency Program (3RP-AYA), to reduce stress and promote stress-management among adolescents and young adults who have completed treatment for cancer.

NCT ID: NCT03768128 Active, not recruiting - Clinical trials for Non-inflammatory Degenerative Joint Disease (NIDJD) of the Knee

Safety and Performance of the Journey™ II UNI Unicompartmental Knee System

JII-Uni
Start date: August 10, 2018
Phase:
Study type: Observational

This clinical study will evaluate the early to midterm safety and performance of the JOURNEY™ II UNI UKS in patients with non-inflammatory degenerative joint disease of the knee requiring lateral or medial knee compartment replacement. Clinical, radiographic, health economic and safety outcomes will be evaluated.

NCT ID: NCT03767803 Active, not recruiting - Hypertension Clinical Trials

Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women

Start date: October 1, 2018
Phase:
Study type: Observational

Whole blood sample procurement study from pregnant women with signs and symptoms of Preeclampsia.

NCT ID: NCT03767257 Active, not recruiting - Multiple Myeloma Clinical Trials

A Study of Colesevelam for Lenalidomide-Associated Diarrhea

Start date: December 3, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test the safety of colesevelam and find out what effects, if any, colesevelam has on lenalidomide associated diarrhea in participants with multiple myeloma on lenalidomide maintenance.

NCT ID: NCT03767244 Active, not recruiting - Prostatic Neoplasms Clinical Trials

A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

PROTEUS
Start date: June 11, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if treatment with apalutamide plus androgen deprivation therapy (ADT) before and after radical prostatectomy (RP) with pelvic lymph node dissection (pLND) in participants with high-risk localized or locally advanced prostate cancer results in an improvement in pathological complete response (pCR) rate and metastasis-free survival (MFS) as compared to placebo plus ADT.

NCT ID: NCT03766191 Active, not recruiting - Childhood Obesity Clinical Trials

Genetic Predisposition to Food Cue Reactivity in Children

Start date: January 10, 2019
Phase: N/A
Study type: Interventional

This study assesses the associations between genetic factors, food-cue-related neural reactivity, self-regulatory capacity, eating in the absence of hunger (EAH), and adiposity gain in children.

NCT ID: NCT03766009 Active, not recruiting - Clinical trials for Breast Cancer Stage II

Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

This trial studies how well a breast cancer surgery decision aid works in increasing patient engagement in decision making for patients with newly diagnosed stage 0-III breast cancer. The trial also examines barriers to patient engagement even with the use of a decision aid, and if barriers are more likely to be experienced by socioeconomically disadvantaged patients.